Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver

Nancy Kemeny, Karen Brown, Anne Covey, Teresa Kim, Amit Bhargava, Lynn Brody, Brenda Guilfoyle, Natasha P. Haag, Matthias Karrasch, Birgit Glasschroeder, Anette Knoll, George Getrajdman, K. Jon Kowal, William R. Jarnagin, Yuman Fong

Research output: Contribution to journal › Article › peer-review

153 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver'. Together they form a unique fingerprint.

Medicine & Life Sciences